Adverse effects include:

- Hematologic: Hemolytic anemia, methemoglobinemia, leukopenia, and agranulocytosis

- Cutaneous hypersensitivity reactions: Mebilliform eruption, exfoliative erythroderma, drug-induced lupus erythematosus, and toxic epidermal necrolysis

- Neurologic: Peripheral neuropathy, predominantly motor loss

- Psychiatric: Psychosis and insomnia

- Eyes: Blurred vision

- Ear, nose, and throat: Tinnitus and vertigo

- Cardiac: Tachycardia

- Pulmonary: Pulmonary Eosinophilia

- Hepatic: Hepatitis, dapsone syndrome, cholestatic jaundice, and hypoalbuminemia without proteinuria

- Gastrointestinal: Nausea, vomiting, abdominal pain, anorexia, and pancreatitis

- Renal: Nephrotic syndrome, albuminuria, and renal papillary necrosis

- Dapsone syndrome: Usually develops after 2 to 6 weeks of dapsone therapy. The characteristic presentation is fever, rash, and hepatitis. The clinical picture may resemble infectious mononucleosis. Blood work will show peripheral eosinophilia and elevated liver enzymes. It can be life-threatening if not adequately treated.